Have drug prices gone up or down? How will you know how much to pay? The Wire breaks it down.
The Swadeshi Jagran Manch has accused the pharmaceutical department of undermining the National Pharmaceutical Pricing Agency and diluting its powers.
NITI Aayog’s research on drug deregulation continues unabated, even as two Union ministers have said they will follow the prime minister’s vision on affordable healthcare.
The government’s premier policy-formulating agency recently recommended measures to deregulate the pharmaceutical sector and make essential medicines more expensive.
Swadeshi Jagran Manch has accused several government arms of lobbying for pharmaceutical companies and negating the NPPA’s attempts to make medicines affordable.
A group of companies plan on telling the government that any further price control measures would make them less likely to introduce new products in the country.
Treating life saving drugs as just another profit making commodity can lead to a big public relations disaster, as an American fund manager discovered